PMID- 22430873 OWN - NLM STAT- MEDLINE DCOM- 20121030 LR - 20160729 IS - 1527-3350 (Electronic) IS - 0270-9139 (Linking) VI - 56 IP - 3 DP - 2012 Sep TI - Hepatitis C virus infection enhances TNFalpha-induced cell death via suppression of NF-kappaB. PG - 831-40 LID - 10.1002/hep.25726 [doi] AB - Hepatitis C virus (HCV) infection results in liver injury and long-term complications, such as liver cirrhosis and hepatocellular carcinoma. Liver injury in HCV infection is believed to be caused by host immune responses, not by viral cytopathic effects. Tumor necrosis factor-alpha (TNF-alpha) plays a pivotal role in the inflammatory processes of hepatitis C. TNF-alpha induces cell death that can be ameliorated by nuclear factor kappaB (NF-kappaB) activation. We investigated the regulation of TNF-alpha signal transduction in HCV-infected cells and identified HCV proteins responsible for sensitization to TNF-alpha-induced cell death. We studied the effect of HCV infection on TNF-alpha signal transduction using an in vitro HCV infection model (JFH-1, genotype 2a) with Huh-7 and Huh-7.5 cells. We found that TNF-alpha-induced cell death significantly increased in HCV-infected cells. HCV infection diminished TNF-alpha-induced phosphorylation of IkappaB kinase (IKK) and inhibitor of NF-kappaB (IkappaB), which are upstream regulators of NF-kappaB activation. HCV infection also inhibited nuclear translocation of NF-kappaB and expression of NF-kappaB-dependent anti-apoptotic proteins, such as B-cell lymphoma--extra large (Bcl-xL), X-linked inhibitor of apoptosis protein (XIAP), and the long form of cellular-FLICE inhibitory protein (c-FLIP). Decreased levels of Bcl-xL, XIAP, and c-FLIP messenger RNA and protein were also observed in livers with chronic hepatitis C. Transfection with plasmids encoding each HCV protein revealed that core, nonstructural protein (NS)4B, and NS5B attenuated TNF-alpha-induced NF-kappaB activation and enhanced TNF-alpha-induced cell death. CONCLUSION: HCV infection enhances TNF-alpha-induced cell death by suppressing NF-kappaB activation through the action of core, NS4B, and NS5B. This mechanism may contribute to immune-mediated liver injury in HCV infection. CI - Copyright (c) 2012 American Association for the Study of Liver Diseases. FAU - Park, Junseong AU - Park J AD - Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea. FAU - Kang, Wonseok AU - Kang W FAU - Ryu, Seung-Wook AU - Ryu SW FAU - Kim, Woo-Il AU - Kim WI FAU - Chang, Dong-Yeop AU - Chang DY FAU - Lee, Dong Ho AU - Lee DH FAU - Park, Do Youn AU - Park DY FAU - Choi, Youn-Hee AU - Choi YH FAU - Choi, Kyungsun AU - Choi K FAU - Shin, Eui-Cheol AU - Shin EC FAU - Choi, Chulhee AU - Choi C LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120726 PL - United States TA - Hepatology JT - Hepatology (Baltimore, Md.) JID - 8302946 RN - 0 (NF-kappa B) RN - 0 (Tumor Necrosis Factor-alpha) SB - IM MH - Cell Death/*physiology MH - Cells, Cultured MH - Hepatitis C/*immunology MH - Humans MH - NF-kappa B/*physiology MH - Tumor Necrosis Factor-alpha/*physiology EDAT- 2012/03/21 06:00 MHDA- 2012/10/31 06:00 CRDT- 2012/03/21 06:00 PHST- 2011/10/26 00:00 [received] PHST- 2012/03/06 00:00 [accepted] PHST- 2012/03/21 06:00 [entrez] PHST- 2012/03/21 06:00 [pubmed] PHST- 2012/10/31 06:00 [medline] AID - 10.1002/hep.25726 [doi] PST - ppublish SO - Hepatology. 2012 Sep;56(3):831-40. doi: 10.1002/hep.25726. Epub 2012 Jul 26.